Trials / Completed
CompletedNCT00613431
Effects of CS-8080 in Healthy Volunteers
A Randomized, Placebo-Controlled, Single Ascending Dose Study To Assess The Safety, Tolerability and Pharmacokinetics Of CS-8080 In Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main purposes of this study are to assess the safety and measure the pharmacokinetics of CS-8080 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CS8080 | CS-8080 tablets will be administered once daily at doses of 1, 3, 10, 20, 50 and 100 mg. |
| DRUG | Placebo | Some subjects will receive matching placebo instead of CS-8080. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-08-01
- First posted
- 2008-02-13
- Last updated
- 2018-12-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00613431. Inclusion in this directory is not an endorsement.